EMPLOYER PERSPECTIVE ON AUGMENTING WORK EXPERIENCES FOR INDIVIDUALS WITH DISABILITIES

The purpose of this study was to investigate employer perspective on augmenting work experiences for individuals with disabilities in the workplace through a qualitative case study approach. This study utilized two specific workplaces that are structured, have core values, are mission-driven and support individuals with differing abilities. The goal was to develop an understanding on how these workplaces continue to help individuals gain meaningful employment while supporting their differences and unique learning approaches in the workplace. Data collection included employer interviews, employee insight, an employer focus group, observations of employees at the work sites, artifacts, photos and the researcher’s journals. Information from national and state guidelines, theoretical perspectives regarding transition and employment for individuals with disabilities, and themes emerging from the data were used for interpretation of the results. Concluding results from the data are high retention rates in employment in mission driven environments as well as a high sense of purpose in a majority of the employees work ethic. There is also data to support personal feelings and connections to employers initiating the business model as well as use of unique interview processes that involve more task orientated practices. In the business environments analyzed in this study, there were more frequent positive interview experiences for individuals with disabilities. The data also supported similar challenges in businesses with social missions, including the need for more soft skill attainment for all individuals when in their school-ages years. The understanding of social context presented difficulties at times for individuals with disabilities when at work, as well as managing hours and work schedules for adults working and receiving state benefits. In New York, individuals receiving special benefits may only be paid a certain number of hours, differing for all individuals. Even if the employee is able and willing to work more hours which is often the case in these environments, there are restrictions for the number of hours employees can pay the individuals. Future studies should include more qualitative research with other businesses with similar business models, practices and social missions. Further qualitative research should include businesses in and outside of the New York area to compare similar practices and help promote new practices in businesses augmenting work experiences for individuals with disabilities in an effort to help improve future employment rates for individuals with differing abilities

Scaling and intermittency of brain events as a manifestation of consciousness

We discuss the critical brain hypothesis and its relationship with intermittent renewal processes displaying power-law decay in the distribution of waiting times between two consecutive renewal events. In particular, studies on complex systems in a "critical" condition show that macroscopic variables, integrating the activities of many individual functional units, undergo fluctuations with an intermittent serial structure characterized by avalanches with inverse-power-law (scale-free) distribution densities of sizes and inter-event times. This condition, which is denoted as "fractal intermittency", was found in the electroencephalograms of subjects observed during a resting state wake condition. It remained unsolved whether fractal intermittency correlates with the stream of consciousness or with a non-task-driven default mode activity, also present in non-conscious states, like deep sleep. After reviewing a method of scaling analysis of intermittent systems based of event-driven random walks, we show that during deep sleep fractal intermittency breaks down, and re-establishes during REM (Rapid Eye Movement) sleep, with essentially the same anomalous scaling of the pre-sleep wake condition. From the comparison of the pre-sleep wake, deep sleep and REM conditions we argue that the scaling features of intermittent brain events are related to the level of consciousness and, consequently, could be exploited as a possible indicator of consciousness in clinical applications

N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity

Thyroid hormone and thyroid hormone metabolites, including 3-iodothyronamine (T1AM) and 3-iodothyroacetic acid (TA1), activate AKT signaling in hippocampal neurons affording protection from excitotoxic damage. We aim to explore whether the mechanism of T1AM neuroprotection against kainic acid (KA)-induced excitotoxicity included the activation of the trace amine associated receptor isoform 1 (TAAR1), one of T1AM targets. Rat organotypic hippocampal slices were exposed to vehicle (Veh) or to 5 μM kA for 24 h in the absence or presence of 0.1, 1 and 10 μM T1AM or to 0.1, 1 and 10 μM T1AM and 1 μM N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB), the only available TAAR1 antagonist, or to 1 μM T1AM in the absence or in the presence of 10 μM LY294002, an inhibitor of phosphoinositide 3-kinases (PI3Ks). Cell death was evaluated by measuring propidium iodide (PI) levels of fluorescence 24 h after treatment. In parallel, the expression levels of p-AKT and p-PKA were evaluated by Western blot analysis of slice lysates. The activity of mitochondrial monoamine oxidases (MAO) was assayed fluorimetrically. 24 h exposure of slices to T1AM resulted in the activation of AKT and PKA. KA exposure induced cell death in the CA3 region and significantly reduced p-AKT and p-PKA levels. The presence of 1 and 10 μM T1AM significantly protected neurons from death and conserved both kinase levels with the essential role of AKT in neuroprotection. Furthermore, EPPTB prevented T1AM-induced neuroprotection, activation of PKA and AKT. Of note, in the presence of EPPTB T1AM degradation by MAO was reduced. Our results indicate that the neuroprotection offered by T1AM depends, as for TA1, on AKT activation but do not allow to conclusively indicate TAAR1 as the target implicated. Graphical abstrac

3-iodothyronamine affects thermogenic substrates’ mobilization in brown adipocytes

We investigated the effect of 3-iodothyronamine (T1AM) on thermogenic substrates in brown adipocytes (BAs). BAs isolated from the stromal fraction of rat brown adipose tissue were exposed to an adipogenic medium containing insulin in the absence (M) or in the presence of 20 nM T1AM (M+T1AM) for 6 days. At the end of the treatment, the expression of p-PKA/PKA, p-AKT/AKT, p-AMPK/AMPK, p-CREB/CREB, p-P38/P38, type 1 and 3 beta adrenergic receptors (β1–β3AR), GLUT4, type 2 deiodinase (DIO2), and uncoupling protein 1 (UCP-1) were evaluated. The effects of cell conditioning with T1AM on fatty acid mobilization (basal and adrenergic-mediated), glucose uptake (basal and insulin-mediated), and ATP cell content were also analyzed in both cell populations. When compared to cells not exposed, M+T1AM cells showed increased p-PKA/PKA, p-AKT/AKT, p-CREB/CREB, p-P38/P38, and p-AMPK/AMPK, downregulation of DIO2 and β1AR, and upregulation of glycosylated β3AR, GLUT4, and adiponectin. At basal conditions, glycerol release was higher for M+T1AM cells than M cells, without any significant differences in basal glucose uptake. Notably, in M+T1AM cells, adrenergic agonists failed to activate PKA and lipolysis and to increase ATP level, but the glucose uptake in response to insulin exposure was more pronounced than in M cells. In conclusion, our results suggest that BAs conditioning with T1AM promote a catabolic condition promising to fight obesity and insulin resistance

Adaptive filtering for removing nonstationary physiological noise from resting state fMRI BOLD signals

fMRI is used to investigate brain functional connectivity after removing nonneural components by General Linear Model (GLM) approach with a reference ventricle-derived signal as covariate. Ventricle signals are related to low-frequency modulations of cardiac and respiratory rhythms, which are nonstationary activities. Herein, we employed an adaptive filtering approach to improve removing physiological noise from BOLD signals. Comparisons between filtering approaches were performed by evaluating the amount of removed signal variance and the connectivity between homologous contralateral regions of interest (ROIs). The global connectivity between ROIs was estimated with a generalized correlation named RV coefficient. The mean ROI decrease of variance was -52% and -11%, for adaptive filtering and GLM, respectively. Adaptive filtering led to higher connectivity between grey matter ROIs than that obtained with GLM. Thus, adaptive filtering is a feasible method for removing the physiological noise in the low frequency band and to highlight resting state functional networks

The Lepidopteran endoribonuclease-U domain protein P102 displays dramatically reduced enzymatic activity and forms functional amyloids

Hemocytes of Heliothis virescens (F.) (Lepidoptera, Noctuidae) larvae produce a protein, P102, with a putative endoribonuclease-U domain. In previous works we have shown that P102 is involved in Lepidopteran immune response by forming amyloid fibrils, which catalyze and localize melanin deposition around non-self intruders during encapsulation, preventing harmful systemic spreading. Here we demonstrate that P102 belongs to a new class of proteins that, at least in Lepidoptera, has a diminished endoribonuclease-U activity probably due to the lack of two out of five catalytically essential residues. We show that the P102 homolog from Trichoplusia ni (Lepidoptera, Noctuidae) displays catalytic site residues identical to P102, a residual endoribonuclease-U activity and the ability to form functional amyloids. On the basis of these results as well as sequence and structural analyses, we hypothesize that all the Lepidoptera endoribonuclease-U orthologs with catalytic site residues identical to P102 form a subfamily with similar function

Mind-body relationships in elite apnea divers during breath holding: a study of autonomic responses to acute hypoxemia

The mental control of ventilation with all associated phenomena, from relaxation to modulation of emotions, from cardiovascular to metabolic adaptations, constitutes a psychophysiological condition characterizing voluntary breath-holding (BH). BH induces several autonomic responses, involving both autonomic cardiovascular and cutaneous pathways, whose characterization is the main aim of this study. Electrocardiogram and skin conductance (SC) recordings were collected from 14 elite divers during three conditions: free breathing (FB), normoxic phase of BH (NPBH) and hypoxic phase of BH (HPBH). Thus, we compared a set of features describing signal dynamics between the three experimental conditions: from heart rate variability (HRV) features (in time and frequency-domains and by using nonlinear methods) to rate and shape of spontaneous SC responses (SCRs). The main result of the study rises by applying a Factor Analysis to the subset of features significantly changed in the two BH phases. Indeed, the Factor Analysis allowed to uncover the structure of latent factors which modeled the autonomic response: a factor describing the autonomic balance (AB), one the information increase rate (IIR), and a latter the central nervous system driver (CNSD). The BH did not disrupt the FB factorial structure, and only few features moved among factors. Factor Analysis indicates that during BH (1) only the SC described the emotional output, (2) the sympathetic tone on heart did not change, (3) the dynamics of interbeats intervals showed an increase of long-range correlation that anticipates the HPBH, followed by a drop to a random behavior. In conclusion, data show that the autonomic control on heart rate and SC are differentially modulated during BH, which could be related to a more pronounced effect on emotional control induced by the mental training to BH

Endovascular management of giant visceral artery aneurysms

Endovascular management of small visceral artery aneurysms is an established treatment with satisfactory outcomes. However, when size exceeds 5 cm visceral aneurysms are considered as “giant” (giant visceral artery aneurysms or GVAAs) and management is significantly more complex. Between August 2007 and June 2019 eleven cases of GVAAs that were endovascularly treated were retrospectively reviewed and included in this single center study. Mean size was 80 mm (± 26.3 mm) x 46 mm (+ -11.8 mm). Nine of the lesions were true aneurysms, and two were pseudoaneurysms. In 8 patients, the lesion was causing compression symptoms in the surrounding organs, one patient developed a contained rupture while 2 patients were completely asymptomatic. However, all patients were hemodynamically stable at the time of treatment. Technical success was defined as immediate complete exclusion of the aneurysmal sac, and clinical success as complete relief from clinical symptoms. Follow-up was performed with CT angiography, ultrasound and clinical examination. Mean follow-up was 45 months (range 6–84). Technical and clinical success were both 91%. Complications were one lack of control of contained rupture that was subsequently operated, one case of self-limiting non-target spleen embolization and one case of splenic abscess. Three patients died, one due to the contained rupture 15 days after procedure, the other two for other causes and occurred during the long-term follow-up. This series suggests that endovascular treatment of giant visceral artery aneurysms and pseudoaneuryms is a valid minimally invasive solution with very satisfactory immediate and long-term outcomes unless the aneurysm is already ruptured. A variety of endovascular tools may be required for successful treatment